Anecdotally, patients on a popular class of weight loss drugs known as glucagon-like peptide receptor agonists are reporting another potential benefit experts are optimistic about: reduced cravings for alcohol.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
